Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults.
about
Migraine in the era of precision medicineThe TRPA1 channel in migraine mechanism and treatmentThe Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult SubjectsThe effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.CGRP receptor antagonism and migraine.The pipeline in headache therapy.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.New treatments for headache.CGRP antagonists and antibodies for the treatment of migraine.Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors.Emerging drugs for migraine treatment.CGRP mechanism antagonists and migraine management.New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors.A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.
P2860
Q26748947-99C4F960-DB0F-4589-A957-1C7D7E2C15C0Q27016641-DF0C6E73-9112-4627-975E-194C50E0C71AQ34462428-7554E5BB-61E2-4D87-AFD9-00D89BD30B8BQ36340711-A4742F49-7A56-49A9-8A38-44A52F841E43Q37374122-A7FAC843-E75C-4BE4-B377-2E5EC6754F96Q38120491-673E0122-4085-404B-A7EA-34111ED78587Q38129436-117DCA60-9607-447E-95EC-C0E9BC5B7D1BQ38130336-9C73E4C3-F572-4B98-97FE-752BE2CDE0FBQ38215470-E7BE579F-15DA-45C6-8564-F26420F3BD96Q38248953-E83BFCF2-8C1E-4162-9B60-D622AF174A91Q38254099-D2A0844E-12EA-4589-848D-59B2C6BE7EC9Q38303376-56B950AF-168E-4FF4-91F5-E7257DABC477Q38384223-8E21EAB3-A1C2-4AAD-A828-7D338C0EC455Q46459487-144C04FC-8A59-4FA9-A6C5-C82C6EB57628Q48745119-E441F83F-4470-48A9-BFFB-AEB1C983223E
P2860
Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@en
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@nl
type
label
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@en
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@nl
prefLabel
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@en
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@nl
P2093
P2860
P356
P1476
Single- and multiple-dose phar ...... eceptor antagonist, in adults.
@en
P2093
Alan J Xiao
Christopher Lines
Deborah Panebianco
Jacqueline B McCrea
Janet Boyle
John Palcza
Kenneth Willson
Lisa Hickey
Luc Van Bortel
M Gail Murphy
P2860
P304
P356
10.1177/0091270010361741
P577
2010-02-19T00:00:00Z